Abstract
Post-marketing surveillance is a mechanism to identify and quantify harmful, as well as beneficial, effects of drugs used under conditions different from those in which they were tested. The College of Family Physicians of Canada collaborated with the authors in a pilot, office-based, post-marketing, surveillance study. Target medications were selected from all prescriptions, written or authorized by participating physicians. The participants collected the prescriptions by using duplicate prescription pads. Follow-up data was collected from the patients by means of a self-administered questionnaire and from the physicians by means of a medical-chart review. This method of research allows the identification of a cohort of drug users in a systematic, non-biased fashion.
Keywords: post-marketing surveillance, duplicate prescriptions
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borden E. K. Post-marketing surveillance: drug epidemiology. J Int Med Res. 1981;9(6):401–407. doi: 10.1177/030006058100900602. [DOI] [PubMed] [Google Scholar]
- Crooks J. The concept of medical auditing. Acta Med Scand Suppl. 1984;683:47–52. doi: 10.1111/j.0954-6820.1984.tb08715.x. [DOI] [PubMed] [Google Scholar]
- Jones L., Simpson D., Brown A. C., Bainton D., McDonald H. Prescribing psychotropic drugs in general practice: three year study. Br Med J (Clin Res Ed) 1984 Oct 20;289(6451):1045–1048. doi: 10.1136/bmj.289.6451.1045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slone D., Shapiro S., Miettinen O. S., Finkle W. D., Stolley P. D. Drug evaluation after marketing. Ann Intern Med. 1979 Feb;90(2):257–261. doi: 10.7326/0003-4819-90-2-257. [DOI] [PubMed] [Google Scholar]